US drug maker Johnson and Johnson will offer its new tuberculosis (TB) drug, Bedaquiline, at $900 (Rs 70,000) once its conditional access programme with the government of India ends in 2019, the company said in an interview to ET.
LONDON: Scientists are developing an eye drop that could revolutionise the treatment for age-related macular degeneration (AMD), the leading cause of blindness in the developed world.
For men planning for fatherhood, regularly consuming a good of nuts can significantly improve men’s firtility and sperm mobility.
Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advancing a novel cancer immunotherapy, announced it received clearance from the FDA to initiate the first Phase 1 clinical trial of its immuno-oncology drug candidate AMXT 1501.
Planegg (pta/08.05.2018/07:30) Medigene AG (MDG1, Frankfurt, Prime Standard), announced that researchers from Max-Delbrück-Center for Molecular Medicine (MDC) and Charité, both in Berlin